[Bengaluru, Karnataka] – NeoDx Biotech Labs, a 3-year-old Bengaluru-based start-up incubated at Bangalore Bioinnovation Centre, has launched 7 Infectious Realtime-PCR Technology-based IVD Kits to empower Healthcare Services to Improve their Testing Capabilities. 

The Seven Kits are designed to detect and quantify the presence of infectious agents for Hepatitis B, Hepatitis C, and HIV, and can help Diagnostic Centres and Hospitals ensure accurate and reliable results. 

Real-time PCR tests can be expensive, and not all laboratories have the budget to perform these tests regularly. The sensitivity and Specificity of the kits are other problem areas that afflict diagnostic centers. In tests that deal with diseases of importance, like Hepatitis B and C, & HIV, Kit performance is non-negotiable. Sensitivity and Specificity become crucial in determining health outcomes. 

The star product of this launch is PathoPlex HIV, HBV & HCV Qualitative RT-PCR Detection Kit, a multiplex single tube assay that detects Hepatitis Virus B and C and HIV 1/2 in a single tube and gives results in 90 minutes. 

Developed under the Start-up India Seed Fund Scheme, NeoDx has launched PathoPlex HIV, HBV, and HCV Qualitative RT-PCR Detection Kit, a game-changer product that can help healthcare professionals test for individual and co-infections using one product, and treat patients with co-existing infections more effectively.

“We recognize the urgent need for accurate and reliable testing in the fight against ending the Hepatitis and HIV Pandemic. We bring these infectious kits to the market to ensure that the Indian healthcare sector does not compromise on test quality and performance, while also benefitting the end user. NeoDx believes in providing high-quality products that are affordable, accessible, and delivers the best performance.” said Dr. Kulkarni, CEO and Co-Founder, NeoDx Biotech Labs. 

The kits have undergone rigorous testing and performance evaluation & are shown to be highly sensitive and specific, along with being compatible with most commercially available RT-PCR platforms. These kits come with all the necessary reagents and controls to perform the tests. NeoDx Biotech Labs also provides technical support and training to ensure that healthcare services can effectively use the kits. 

NeoDx Biotech Labs is committed to improving global health by developing innovative biotechnology solutions. With the launch of these seven new RT-PCR kits, the company hopes to continue contributing to the fight against Hepatitis and HIV/AIDS, this will aid in achieving the national aim to eliminate hepatitis by 2030 and support healthcare services in their efforts to provide accurate and reliable testing.

To learn more, go to www.neodx.in

NeoDx Biotech Labs has come out with 7 Real-time PCR Based Kits for infectious diseases including Hepatitis B, Hepatitis C, and HIV to ease the burden of testing by diagnostic centers and hospitals